HCW Biologics is trading 5.25% down at $3.25 after a sharp multi-session rally.
- Shares gained 17.41% on August 27 and 8.20% on August 28.
- No company-specific announcement dated August 31, 2026, has been identified to explain the decline.
- The broader market is also lower, but the move is not large enough to establish a clear macro-driven cause. Recent news includes August 25 research updates and August 14 financial results.